Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCELERATE evacetrapib outcomes study
2012-000061-21Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Vasculopathy, arteriosclerosis obliterans and cardiac morbidity comparing Evacetrapib with Placebo (2 arms). Started Jul 2012; status: completed.
02
Drugs
evacetrapib
03
Conditions
Vasculopathyarteriosclerosis obliteranscardiac morbidity
Beyond the preview
Go deeper on 2012-000061-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000061-21.